Fused bicyclic pyridine derivatives as tachykinin receptor...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S234200, C514S302000, C540S455000, C540S490000

Reexamination Certificate

active

07030107

ABSTRACT:
A novel fused bicyclic pyridine derivative or a salt thereof that acts as a tachykinin receptor antagonist, in particular as an NK1 receptor antagonist, is represented by the following general formula (1):wherein the rings A and B are each a benzene ring which may have 1 to 3 substituents (any adjacent two of which may be bound to one another to form a ring);the ring C is a nitrogen-containing ring having a hydrogen atom substituted with a nitrogen atom;R1and R2are each independently a hydrogen atom, a C1to C6alkyl group, a C1to C6alkylsulfonyl group, a C1to C6alkylcarbonyl group, or a C1to C6alkoxycarbonyl group, or R1and R2are bound to one another to form the ring D; m is 1 or 2; n is 2 or 3; and q is an integer from 1 to 4.

REFERENCES:
patent: 6147071 (2000-11-01), Natsugari et al.
patent: 652218 (1995-05-01), None
patent: 97/24356 (1997-07-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fused bicyclic pyridine derivatives as tachykinin receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fused bicyclic pyridine derivatives as tachykinin receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic pyridine derivatives as tachykinin receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3550217

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.